Boston Scientific to buy Preventice Solutions for $925m
Preventice provides a portfolio of mobile cardiac health solutions and services
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
22 Jan 21
Preventice provides a portfolio of mobile cardiac health solutions and services
AdvaMed and the MDMA have led the US medtech industry in congratulating President Joe Biden and Vice President…
21 Jan 21
The mobile testing toolkit will help administer on-site Covid-19 rapid testing and real-time tracking in high-volume settings
21 Jan 21
PRECISION1 for Astigmatism features PRECISION BALANCE 8|4 lens design, which helps to provide stable lens-wearing experience
20 Jan 21
Researchers in Canada compared Parsortix to the only FDA approved test for circulating tumour cells and found it…
20 Jan 21
The acquisition will help DJO to focus more on expanding into the $1bn US foot and ankle market
20 Jan 21
Mesa Biotech has developed a PCR-based rapid point-of-care testing platform to detect infectious diseases such as SARS-CoV-2
19 Jan 21
Researchers from Washington University School of Medicine believe they can tell which Covid-19 patients will need urgent care…
19 Jan 21
The genomic sequencing will be used to detect new mutations in, and patterns of transmission of SARS-CoV-2
19 Jan 21
The advanced assay kit is capable of diagnosing depression and bipolar disorder